OICR News / Tag

Michael Taylor

Browse news tagged Michael Taylor.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

CollaborationClinical trials

“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers

OICR’s Translational Research Initiatives (TRIs) made a lasting impact for patients. In 2017, ovarian cancer research was due for a new approach. Despite the best efforts of scientists, clinicians and patients, outcomes hadn’t improved for…

ArticleFeb 28, 2024

TechnologyTreatment

New findings pave the way for future brain cancer research and drug development

OICR-supported study finds key mechanisms driving a severe form of brain cancer affecting infants and toddlers When a young child is diagnosed with ependymoma, their treatment options are limited to surgery and radiation therapy –…

ArticleJun 09, 2020

TechnologyTreatment

New treatment for recurrent pediatric brain cancer enters clinical testing

OICR-supported study helps move promising CAR-T cell therapy into a first-in-child clinical trial Recurrent brain tumours are some of the most difficult cancers to treat, with no approved targeted therapies available and only a few…

ArticleMay 06, 2020

TechnologyMultiple cancers

Researchers discover a new cancer-driving mutation in the “dark matter” of the cancer genome

Change in just one letter of DNA code in a gene conserved through generations of evolution can cause multiple types of cancer Toronto – (October 9, 2019) An Ontario-led research group has discovered a novel…

ArticleOct 09, 2019

TechnologyBrain cancer

The unanticipated early origins of childhood brain cancer

Study identifies earliest traces of brain cancer long before the disease becomes symptomatic Toronto (May 1, 2019) - Brain tumours are the leading cause of non-accidental death in children in Canada, but little is known…

ArticleMay 01, 2019

CollaborationTreatment

Collaborating to bring new treatment options to children with brain cancer

OICR's Brain Cancer Translational Research Initiative (TRI) and the Terry Fox Precision Oncology for Young People Program (PROFYLE) are partnering to share data and deliver improved treatment options to young brain cancer patients. Cancer is…

ArticleMar 08, 2018

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Michael Taylor

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

“Dream team” science helps move Ontario ahead of the curve on hard-to-treat cancers

New findings pave the way for future brain cancer research and drug development

New treatment for recurrent pediatric brain cancer enters clinical testing

Cancer solved together — in your inbox

Researchers discover a new cancer-driving mutation in the “dark matter” of the cancer genome

The unanticipated early origins of childhood brain cancer

Collaborating to bring new treatment options to children with brain cancer